Thrive Capital

When Joshua Kushner launched Thrive Capital in 2009 at age 24, skeptics called it a hobby. When he raised $40M for Fund II in 2011, the chatter shifted to skepticism about his age and deal volume. When Thrive closed Fund X at $10B in February 2026 — the largest fund in the firm's history — the conversation changed again. Thrive Capital has become one of the most consequential growth-stage firms in venture, deploying capital across software, internet, and AI-native businesses at scale. Understanding NRR and why top quartile exceeds 120% is valuable for any founder.

The firm's latest fund broke records: $1B allocated to early-stage bets, $9B reserved for growth and pre-IPO rounds. That structure tells you everything about Thrive's philosophy — they want to own the full lifecycle of category-defining companies, from first meaningful check through public markets.

In late 2024, Thrive made one of the most talked-about investments in recent venture history: approximately $1B into OpenAI at a $150B valuation, with Thrive negotiating exclusive rights to invest another $1B in future rounds. That single deal demonstrated the firm's willingness to write transformative checks when conviction is high.

Unlike traditional growth funds that spread capital across dozens of positions, Thrive runs a concentrated portfolio. The firm prefers fewer but larger bets, staying involved across multiple rounds as companies scale toward IPO. This approach requires deep conviction — and explains why Thrive's 2022-2024 vintage delivered an estimated 25% IRR.

For founders considering Thrive Capital, the message is consistent: come with real traction, a clear path to market leadership, and an honest assessment of what you're building. The firm has seen thousands of pitches. What gets their attention is evidence that you're creating or redefining a category — not competing in one.

Thrive Capital's thesis is straightforward but demanding: they invest in companies building category-defining businesses in software and internet markets. The firm's focus on software is deliberate — it reflects a belief that software businesses offer the most predictable paths to scale, margin expansion, and durable competitive moats. Understanding unit economics and LTV:CAC is valuable for any founder.

What sets Thrive apart from many growth-stage peers is their willingness to invest across the spectrum. The $1B early-stage allocation within Fund X signals that Thrive doesn't want to miss founders they first backed at seed when those companies hit growth-stage inflection points. The $9B growth bucket is reserved for companies demonstrating clear product-market fit and ready for meaningful market expansion.

Thrive looks for businesses with evidence of compounding growth trajectories — not just strong quarter-over-quarter numbers, but metrics that show accelerating return on capital as the business scales. The firm has developed a reputation for identifying companies approaching inflection moments where growth becomes self-reinforcing.

The firm's New York roots give them a distinct angle on certain markets — particularly fintech, health tech, and consumer internet — but Thrive invests globally when conviction is strong. Their portfolio spans everything from AI infrastructure (Scale AI) to entertainment (A24) to enterprise software (Figma) to classifieds and marketplace businesses.

Thrive evaluates investments through a lens of long-term market leadership. They want to understand not just where a company is today but what structural advantages it will have in five years that competitors cannot easily replicate. This means proprietary data, network effects, brand, and switching costs all factor into due diligence.

The firm's concentrated approach means Thrive can afford to be selective. They are not trying to own every hot sector — they are looking for the few companies in any given market that have the potential to become definitive infrastructure for their industries.

Fund X's $10B size is a statement about ambition. Thrive's previous funds were large by venture standards, but $10B puts them in a different category — closer to growth equity than traditional venture Understanding EBITDA multiples in growth-stage valuation helps founders navigate this. This changes the firm's positioning in two meaningful ways: they can write checks that reshape cap tables, and they can support companies all the way through pre-IPO stages without needing to exit prematurely.

The split between early-stage ($1B) and growth ($9B) is strategic. Thrive has watched companies they backed early get poached by growth funds when it came time to raise expansion capital. Fund X's structure allows Thrive to follow those winners into later rounds — and to compete for allocation in companies they didn't originally back.

Founders should understand what Fund X means for competitive dynamics. Thrive now has the capital to lead or co-lead rounds that previously would have gone to multi-fund firms like Sequoia or a16z. At the same time, the firm isn't using its capital to dominate companies — their model still depends on being invited into the best deals, which requires strong founder relationships.

The OpenAI investment is the clearest signal of how Thrive thinks about Fund X deployment. A $1B check into a single company at a $150B valuation isn't a typical venture allocation — it's a conviction bet on a company Thrive believes will be generational infrastructure. Expect more of these types of deals as Fund X gets deployed.

Thrive has also demonstrated interest in non-traditional investment structures. Their Thrive Holdings vehicle is designed to acquire and roll up smaller companies that can benefit from AI integration and operational leverage — a more private equity-inspired approach that sits alongside their traditional venture bets.

Thrive's portfolio reads like a tour through the last decade's most consequential tech businesses. Instagram (acquired by Facebook for $1B), Spotify, Slack (acquired by Salesforce for $27.7B), and Stripe represent the firm's early track record of identifying category leaders before they became obvious giants. Those investments built the reputation that now draws inbound deal flow.

Scale AI represents Thrive's conviction in AI infrastructure. Founded in 2019, Scale emerged as the critical data labeling and annotation platform powering AI development at major enterprises and AI labs. Thrive's involvement came during a period when many traditional VCs were still dismissing the AI infrastructure thesis as premature.

A24 is the outlier in Thrive's portfolio — a film and entertainment studio that redefined independent cinema with films like 'Everything Everywhere All at Once.' The investment reflects Thrive's willingness to back category-creating businesses outside traditional tech verticals, as long as the founder has a clear vision for how the category evolves.

Figma, the collaborative design platform acquired by Adobe for $20B, is another landmark Thrive investment. The company's rise from niche design tool to enterprise collaboration platform demonstrated how Thrive identifies software categories before they become crowded.

Thrive's more recent portfolio includes Carvana (online car sales disrupting automotive retail), Oscar Health (tech-enabled health insurance), StubHub (event ticketing marketplace), Reddit (social platform that went public in 2024), and Flexport (freight forwarding and logistics). Each represents a sector being structurally transformed by technology — Thrive's core investment theme.

The common thread across Thrive's portfolio is founders who had a clear view of how their category would evolve and the operational skill to execute on that vision. Thrive doesn't back incremental improvements — they back businesses that redefine how industries work.

Thrive evaluates founders on two dimensions: domain conviction and operational execution ability. They want to see that a founder understands their market at a level that goes beyond what can be learned from market research — deep, granular knowledge of where the industry is heading and why existing solutions are structurally inadequate.

The firm's concentrated portfolio means they spend real time with each investment. Thrive partners are involved in board work, strategic decisions, and founder support in ways that go beyond most growth funds. This means they are selective about who they partner with — and it also means founders should be clear about whether they want that level of involvement before approaching Thrive.

Thrive looks for evidence of founder-driven category creation. They are not looking for fast followers or companies that execute on an existing model better than incumbents — they want founders who have a point of view about how the category should look in five to ten years and are building toward that vision with clear milestones.

Financial metrics matter, but not in the way early-stage investors might expect. Thrive at growth stage wants to see that the unit economics scale favorably — that growth doesn't require proportional increases in spending to sustain. They are looking for businesses where each additional dollar of revenue is more profitable than the last.

Team depth is increasingly important at the growth stage. Thrive wants to see that founders have built management teams capable of scaling the organization without the founder needing to be involved in every decision. A company at Series B or C that still operates like a ten-person startup signals execution risk.

Thrive is candid about what they don't back: companies with weak competitive moats, markets that are easily disrupted by incumbents, and founders who are reactive rather than visionary. The firm's philosophy is that at growth stage, the window for correcting strategic errors narrows — so the initial bet has to be on the right trajectory.

Thrive's check sizes have grown alongside their fund sizes. Where early funds wrote $5M to $20M checks, Fund X allows Thrive to write $25M to $500M+ into growth-stage rounds. The firm is capable of writing the full round for companies that need meaningful capital to execute on their growth plans.

At the early stage (Fund X's $1B allocation), Thrive participates in Series A and Series B rounds, typically investing $10M to $50M. The growth allocation covers Series B, Series C, and pre-IPO rounds, with the ability to lead or co-lead transactions that might otherwise go to larger multi-fund firms.

Thrive prefers to lead or co-lead growth-stage rounds, taking board seats and actively participating in company strategy. The firm does occasionally participate in rounds as a passive investor when a strong existing relationship or founder preference calls for it, but the default is active involvement.

The OpenAI deal demonstrated Thrive's ability to move large amounts of capital quickly and with conviction. Thrive negotiated exclusive access to a $1B investment at a $150B valuation — this required both the capital to deploy and the relationship credibility to win allocation in what became one of the most competitive deals in venture history.

For founders, understanding Thrive's check size flexibility is important for fundraising strategy. If you're raising a $50M Series C and Thrive is interested, they can potentially own a meaningful portion of the round — reducing the need to run a full process with multiple lead investors. That can be a significant advantage in competitive markets.

Follow-on investment is part of Thrive's model. The firm's track record shows consistent support for portfolio companies across multiple financing rounds. If Thrive leads your Series B, there's a reasonable expectation they will participate in the Series C if the company is executing to plan.

Warm introductions remain the primary path to Thrive's partnership. The firm's deal flow is dominated by inbound from their network of founders, co-investors, and advisors — which means cold outbound has a lower hit rate than at firms with more formal sourcing operations. Building relationships with Thrive partners before fundraising is the highest-leverage strategy.

The firm's New York base gives them deep connectivity to East Coast founder networks, but Thrive invests globally. The key is demonstrating that your business fits their thesis — not just operationally but in terms of the story and ambition of what you're building. Founders who can articulate why they are creating a new category rather than competing in an existing one get the most attention.

Thrive's website at thrivecap.com has limited information about the firm or how to submit. For founders without direct network connections, the best approach is to seek introductions through portfolio company founders, growth-stage investors who co-invest with Thrive, or advisors who have worked with the firm before.

When you do get a meeting with Thrive, come prepared with clarity on the market opportunity, your competitive differentiation, and the specific metrics that demonstrate product-market fit. The firm's partners will challenge your assumptions — particularly around the durability of your competitive moat and the scalability of your unit economics. Be ready for rigorous debate.

Thrive's investment process for growth-stage deals typically takes four to eight weeks from initial meeting to term sheet. The firm conducts thorough due diligence but moves decisively when conviction is established. If you've reached the point where Thrive is discussing investment terms, expect a collaborative but intensive process.

Even if your current round doesn't result in an investment, Thrive maintains relationships with founders over time. A company that isn't right for Thrive at Series B may be appropriate at Series D, or Thrive may introduce you to other investors who are a better fit. The firm tends to think in terms of multi-year founder relationships.

At the growth stage, investors expect founders to have command of their financial model in ways that go beyond early-stage pitch decks. Thrive will scrutinize your path to profitability, your unit economics at scale, and your assumptions about how the business evolves as you grow revenue from tens of millions to hundreds of millions.

Working capital management becomes a significant factor at growth stage. Thrive wants to understand how your business deploys capital — particularly in businesses with recurring revenue metrics models where ARDS and contract liabilities create balance sheet complexity. Founders who have mastered their working capital dynamics demonstrate the operational depth that growth-stage investors value.

A fractional CFO engagement is one of the highest-ROI preparations a growth-stage founder can make before pitching Thrive. Professional financial leadership ensures your data room is investor-ready, your projections are grounded in evidence, and your Q&A performance reflects deep understanding of your business mechanics rather than surface-level familiarity.

Board reporting quality matters at this stage. Thrive will evaluate how your board materials are structured and whether the metrics you track are the ones that actually drive business value. Companies with best-in-class board reporting demonstrate operational maturity that translates to trust in the founder's ability to scale.

When preparing financial models for Thrive, err on the side of granular bottoms-up assumptions rather than top-down market sizing. The firm's partners will challenge every assumption, and models that show evidence of deep operational understanding perform better than decks that rely on large market TAM projections without supporting logic.

Understanding your KPIs at a granular level is expected at growth stage. Thrive wants to see that you know which metrics drive your business, how they trend across customer cohorts, and what early signals of churn or contraction look like in your data. This is the difference between founders who are operationally excellent and those who are still learning.

Thrive's concentrated portfolio approach means they carry fewer but more meaningful positions than most growth funds. Where a typical growth fund might have forty positions, Thrive has historically run a more selective portfolio — which means each investment receives more attention and the firm's reputation for being selective is earned, not manufactured.

The firm's New York origins give them a slightly different cultural lens than Sand Hill Road-based peers. Thrive tends to be more direct in founder interactions, faster in decision-making, and less bureaucratic in structure. For founders who find larger multi-partner firms slow or diffuse, Thrive's smaller partnership can feel markedly different.

Thrive's willingness to invest across the full lifecycle — from early-stage conviction bets through large growth checks — is unique. Most funds are structured either as early-stage or growth; Thrive's Fund X structure explicitly crosses that boundary. This creates a path for founders to build a relationship with Thrive early and have it compound over multiple rounds.

The firm's personal connection to founders is deeper than most institutional investors. Joshua Kushner and the partnership have built personal relationships with many of the most consequential founders of the last decade — and those relationships generate deal flow that no amount of outbound sourcing can replicate. Thrive gets into the best deals because founders want them there.

For founders evaluating Thrive against other growth options, the key question is fit: do you want an active partner who will push your thinking and engage deeply in company strategy, or do you prefer a more passive capital partner? Thrive is emphatically the former — and that intensity is not for every founder or every company.